 Molecular Partners AGs NASDAQ: MOLN collaborating partner Amgen Inc NASDAQ: AMGN for MP0310 AMG 506 will return the global rights of MP0310 to Molecular Partners following a strategic pipeline review. MP0310 is a dual-targeted compound targeting both FAP. 